Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgens and other hormones affect hair growth and skin conditions like acne.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Low testosterone may increase COVID-19 severity in men.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

AR gene variations don't affect aging markers in men.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Lowering testosterone speeds up wound healing in male mice.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.